文献速递消化内镜消化道肿瘤与早癌

日本全国多中心前瞻性研究:结肠胶囊内镜的实用性、安全性与可接受性

Nationwide multicenter prospective study on the usefulness, safety, and acceptability of colon capsule endoscopy in Japan.
PubMed 文献 · Gastrointest Endosc · 2024-11-08

该研究在日本44家医院前瞻性纳入1006例接受第二代结肠胶囊内镜(CCE)检查的疑似或确诊结直肠疾病患者,评估全结肠检查完成率、肠道清洁充分率、结直肠息肉或肿瘤检出率、不良事件及可接受性。结果显示全结肠检查率为86.1%,总体肠道清洁充分率为65.5%,对≥6 mm和≥10 mm结直肠息肉或肿瘤患者的检出率分别为92%(95%CI 84-97)和89%(95%CI 78-96),胶囊滞留发生2例(0.20%),63%患者希望下次结肠镜检查选择CCE。结论认为在充分肠道准备下,CCE相对安全、耐受良好且对检出结直肠病变有用。

要点

  • 全结肠检查率86.1%,总体肠道清洁充分率65.5%。
  • 对≥6 mm和≥10 mm结直肠息肉或肿瘤患者的检出率分别为92%和89%。
  • 胶囊滞留2例(0.20%),63%患者希望下次选择CCE。

核心结论

  • 在充分肠道准备下,第二代结肠胶囊内镜(CCE)相对安全、耐受良好且对检出结直肠病变有用。

研究设计与样本

  • 日本44家医院参加的前瞻性多中心研究,纳入1006例疑似或确诊结直肠疾病并接受CCE检查的患者。
  • 临床试验注册号:UMIN000021936。

主要发现

  • 全结肠检查率为86.1%。
  • 总体肠道清洁充分率为65.5%。
  • 对≥6 mm和≥10 mm结直肠息肉或肿瘤患者的检出率分别为92%(95%CI 84-97)和89%(95%CI 78-96)。
  • 胶囊滞留发生2例(0.20%),需内镜和外科干预。
  • 63%患者希望下次结肠镜检查选择CCE。

关键数值与推荐

  • 全结肠检查的独立预测因素:年龄小于63岁(aOR 1.525)、男性(aOR 1.496)、炎症性肠病(aOR 1.889)、第-1天灌洗液摄入(aOR 1.625)、第0天灌洗液摄入≥1800 mL(aOR 0.595)、第0天促动力药(aOR 0.608)、第0天蓖麻油 booster ≥30 mL(aOR 1.734)。
  • 肠道清洁充分的独立预测因素:便秘(aOR 0.527)、第-1天灌洗液摄入(aOR 1.822)、第-1天泻药摄入(aOR 2.616)、第0天灌洗液摄入≥1900 mL(aOR 1.449)。
  • 检出≥6 mm结直肠息肉或肿瘤的独立预测因素:升结肠清洁不充分(aOR 0.184)、横结肠≥6 mm结直肠息肉或肿瘤(aOR 4.703)、左侧结肠≥6 mm结直肠息肉或肿瘤(aOR 32.013)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: We determined the factors influencing total capsule colonoscopy, adequate cleansing, and detectability of second-generation colon capsule endoscopy (CCE) for colorectal polyps or tumors (CRTs), adverse events, and acceptability. METHODS: Among 44 Japanese hospitals, 1006 patients with suspected or documented colorectal diseases who underwent CCE were enrolled prospectively. RESULTS: The total capsule colonoscopy rate was 86.1%. Age younger than 63 years (adjusted odds ratio [aOR], 1.525), male sex (aOR, 1.496), inflammatory bowel disease (aOR, 1.889), lavage intake on day -1 (aOR, 1.625), ≥1800-mL lavage intake on day 0 (aOR, .595), prokinetics on day 0 (aOR, .608), and ≥30-mL castor oil booster on day 0 (aOR, 1.734) were significant independent predictors. The overall adequate cleansing rate was 65.5%. Constipation (aOR, .527), lavage intake on day -1 (aOR, 1.822), laxative intake on day -1 (aOR, 2.616), and ≥1900-mL lavage intake on day 0 (aOR, 1.449) were significant independent predictors. The detection rates for patients with CRTs ≥6 mm and ≥10 mm were 92% (95% confidence interval, 84-97) and 89% (95% confidence interval, 78-96), respectively. Inadequate cleansing in the ascending colon (aOR, .184), ≥6-mm CRT in the transverse colon (aOR, 4.703), and ≥6-mm CRT in the left-sided colon (aOR, 32.013) were significant independent predictors. CCE retention occurred in 2 patients (.20%) requiring endoscopic and surgical interventions. In total, 63% of patients desired CCE for their next colonoscopy. CONCLUSIONS: CCE was relatively safe, well tolerated, and useful for detecting colorectal lesions when adequate bowel preparation was made. (Clinical trial registration number: UMIN000021936.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Hotta N, Ohmiya N, Hiraga H, et al. Nationwide multicenter prospective study on the usefulness, safety, and acceptability of colon capsule endoscopy in Japan. Gastrointest Endosc. 2024. PMID: 39521091. doi:10.1016/j.gie.2024.11.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。